BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16520550)

  • 1. Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.
    Lee KH; Choi EY; Kim MK; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
    Exp Mol Med; 2006 Feb; 38(1):27-35. PubMed ID: 16520550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
    Lee KH; Hyun MS; Kim JR
    Clin Exp Metastasis; 2003; 20(6):499-505. PubMed ID: 14598883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanisms of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MAPK signaling in hepatocellular carcinoma.
    Lee KH; Choi EY; Hyun MS; Eun JR; Jang BI; Kim TN; Lee HJ; Lee DS; Yun SS; Kim HJ; Kim JH; Kim JR
    Tumori; 2008; 94(4):523-30. PubMed ID: 18822689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer.
    Lee KH; Kim JR
    Oncol Res; 2009; 18(2-3):107-16. PubMed ID: 20066900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment.
    Lee KH; Choi EY; Koh SA; Kim MK; Jang BI; Kim SW; Kim JR
    Oncol Rep; 2014 May; 31(5):2123-30. PubMed ID: 24626561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: A potential therapeutic target for human stomach cancer.
    Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
    Korean J Intern Med; 2006 Mar; 21(1):20-7. PubMed ID: 16646560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells.
    Lee KH; Kim SW; Kim JR
    J Exp Clin Cancer Res; 2009 Jun; 28(1):73. PubMed ID: 19497102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma inhibits hepatocyte growth factor-stimulated cell proliferation of human bronchial epithelial cells: upregulation of p27(kip1) cyclin-dependent kinase inhibitor.
    Takami K; Takuwa N; Okazaki H; Kobayashi M; Ohtoshi T; Kawasaki S; Dohi M; Yamamoto K; Nakamura T; Tanaka M; Nakahara K; Takuwa Y; Takizawa H
    Am J Respir Cell Mol Biol; 2002 Feb; 26(2):231-8. PubMed ID: 11804875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1.
    Ding XZ; Adrian TE
    Biochem Biophys Res Commun; 2001 Mar; 282(2):447-53. PubMed ID: 11401480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
    Han YC; Zeng XX; Wang R; Zhao Y; Li BL; Song M
    Ai Zheng; 2007 Jan; 26(1):48-53. PubMed ID: 17222367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
    Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor.
    Lee KH; Kim JR
    Exp Mol Med; 2009 Mar; 41(3):180-8. PubMed ID: 19293637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines.
    Okusa Y; Ichikura T; Mochizuki H; Shinomiya N
    Int J Oncol; 2000 Nov; 17(5):1001-5. PubMed ID: 11029504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.
    Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Lee HJ; Eun JY; Kim HG; Yoon SS; Lee DS; Kim JH; Kim JR
    Clin Exp Metastasis; 2008; 25(1):89-96. PubMed ID: 17992475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration.
    Jo M; Thomas KS; Somlyo AV; Somlyo AP; Gonias SL
    J Biol Chem; 2002 Apr; 277(14):12479-85. PubMed ID: 11805108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma cells.
    Chattopadhyay N; Tfelt-Hansen J; Brown EM
    Brain Res Mol Brain Res; 2002 Jun; 102(1-2):73-82. PubMed ID: 12191496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion.
    Montero L; Nagamine Y
    Cancer Res; 1999 Oct; 59(20):5286-93. PubMed ID: 10537311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
    Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Shinagawa K; Teshima T; Ishimaru F; Ikeda K; Tanimoto M
    Oncology; 2004; 67(3-4):310-9. PubMed ID: 15557793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.